Literature DB >> 2726729

Biostatistical analysis of mortality data for cohorts of cancer patients.

L Pauling1.   

Abstract

The Hardin Jones principle states that for a homogeneous cohort of cancer patients the logarithm of the fraction surviving at time t has a constant slope. With use of this principle, the survival times of the members of a heterogeneous cohort can be analyzed to divide the cohort into subcohorts with different mortality rate constants. Probable values of the additional survival time can be estimated for members surviving at the closing date of a clinical trial, permitting them to be included in the biostatistical analysis of the results of the trial in a more significant way than through Kaplan-Meier renormalization.

Entities:  

Mesh:

Year:  1989        PMID: 2726729      PMCID: PMC287158          DOI: 10.1073/pnas.86.10.3466

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  3 in total

1.  Demographic consideration of the cancer problem.

Authors:  H B JONES
Journal:  Trans N Y Acad Sci       Date:  1956-02

2.  Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

  3 in total
  1 in total

1.  Criteria for the validity of clinical trials of treatments of cohorts of cancer patients based on the Hardin Jones principle.

Authors:  L Pauling; Z S Herman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.